Badgley Phelps Wealth Managers, LLC Seagen Inc. Transaction History

Badgley Phelps Wealth Managers, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 28, 2023	BUY	$127.59 - $203.08 $50,270 - $80,013	394 Added 22.51%	2,144 $434,000
Q1 2022 May 09, 2022	SELL	$119.61 - $157.85 $23,922 - $31,570	-200 Reduced 10.26%	1,750 $252,000
Q3 2021 Nov 29, 2021	BUY	$142.45 - $169.82 $277,777 - $331,149	1,950 New	1,950 $331,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Badgley Phelps Wealth Managers, LLC, based on Form 13F filings with the SEC.

Stay updated on Badgley Phelps Wealth Managers, LLC with notifications on news.